Radiation sickness

Free

E-Newsletters

Subscribe to receive the latest updates on health topics. About our newsletters

  • Housecall
  • Alzheimer's caregiving
  • Living with cancer

Treatments and drugs

By Mayo Clinic staff

Radiation sickness treatment is aimed at preventing further radioactive contamination, managing organ damage, reducing symptoms and managing pain.

Decontamination
This phase of radiation sickness treatment removes external radioactive particles to the greatest extent possible. Removing clothing and shoes eliminates about 90 percent of external contamination. Gently washing with water and soap removes additional radiation particles from the skin.

Decontamination at the start of radiation sickness treatment prevents further distribution of radioactive materials and lowers the risk of internal contamination from inhalation, ingestion or open wounds.

Treatment for damaged bone marrow
A protein called granulocyte colony-stimulating factor, which promotes the growth of white blood cells, is used in radiation sickness treatment to counter bone marrow damage. This protein-based medication, which includes filgrastim (Neupogen) and pegfilgrastim (Neulasta), may increase white blood cell production and help prevent subsequent infections.

If you have severe damage to bone marrow, radiation sickness treatment may also include transfusions of red blood cells or blood platelets.

Treatment for internal contamination
Some radiation sickness treatments may reduce organ damage caused by radioactive particles. Medical personnel would use these treatments only if you've been exposed to a specific type of radiation. These treatments include the following:

  • Potassium iodide. This is a nonradioactive form of iodine. Because iodine is essential for proper thyroid function, the thyroid becomes a "destination" for iodine in the body. If you have internal contamination with radioactive iodine (radioiodine), your thyroid will absorb radioiodine just as it would other forms of iodine. Treatment with potassium iodide may fill "vacancies" in the thyroid and prevent absorption of radioiodine. The radioiodine is eventually cleared from the body in urine.
  • Prussian blue. This type of dye binds to particles of radioactive elements known as cesium and thallium. The radioactive particles are then excreted in feces. This treatment speeds up the elimination of the radioactive particles and reduces the amount of radiation cells may absorb.
  • Diethylenetriamine pentaacetic acid (DTPA). This substance binds to metals. DTPA binds to particles of the radioactive elements plutonium, americium and curium. The radioactive particles pass out of the body in urine, thereby reducing the amount of radiation absorbed.

Supportive treatment
If you have radiation sickness, you may receive additional medications or interventions to treat:

  • Bacterial infections
  • Headache
  • Fever
  • Diarrhea
  • Nausea and vomiting
  • Dehydration

End-of-life care
A person who has absorbed large doses of radiation (6 Gy or greater) has little chance of recovery. Depending on the severity of illness, death can occur within two days or two weeks. People with a lethal radiation dose will receive medications to control pain, nausea, vomiting and diarrhea. They may also benefit from psychological or pastoral care.

References
  1. Upton AC. Radiation injury. In: Goldman L, et al., eds. Cecil Medicine. 23rd ed. Philadelphia, Pa.: Saunders Elsevier; 2007. http://www.mdconsult.com/das/book/body/190749348-4/972374138/1492/93.html#4-u1.0-B978-1-4160-2805-5..50023-9--cesec10_713. Accessed March 23, 2010.
  2. Colwell CB, et al. Radiation injuries. In: Marx JA, et al., eds. Rosen's Emergency Medicine: Concepts and Clinical Practice. 6th ed. St. Louis, Mo.: Mosby; 2006. http://www.mdconsult.com/book/player/book.do?method=display&type=bookPage&decorator=header&eid=4-u1.0-B978-0-323-05472-0..00144-4&uniq=190749348&isbn=978-0-323-05472-0&sid=972411702. Accessed March 23, 2010.
  3. Siegel D. Preparation for terrorist threats: Radiation injury. Clinical Pediatric Emergency Medicine. 2009;10:136.
  4. Bushberg JT. Radiation exposure and contamination. The Merck Manuals: The Merck Manual for Healthcare Professionals. http://merck.com/mmpe/sec21/ch317/ch317a.html#CHDCIEIA. Accessed March 23, 2010.
  5. Ferri FF, et al. Radiation exposure. In: Ferri FF. Ferri's Clinical Advisor 2010. St. Louis, Mo.: Mosby; 2009. http://www.mdconsult.com/das/book/body/190749348-10/972432685/2088/550.html#4-u1.0-B978-0-323-05609-0..00027-7--s0170_11313. Accessed March 23, 2010.
  6. Vetter RJ (expert opinion). Mayo Clinic, Rochester, Minn. April 3, 2010.
DS00432 March 17, 2011

© 1998-2012 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

Print Share Reprints

Advertisement


Text Size: smaller largerlarger